Idarucizumab for Reversing Anticoagulation in Adults Treated with Dabigatran: A Review of the Clinical Effectiveness, Cost-effectiveness, and Guidelines [Internet].

This report was reviewed by experts in the treatment of venous thromboembolism and emergency medicine.

http://ift.tt/2ui4h6C